Literature DB >> 15034026

Effect of decreasing the affinity of the class II-associated invariant chain peptide on the MHC class II peptide repertoire in the presence or absence of H-2M.

Karen Honey1, Katherine Forbush, Peter E Jensen, Alexander Y Rudensky.   

Abstract

The class II-associated invariant chain peptide (CLIP) region of the invariant chain (Ii) directly influences MHC class II presentation by occupying the MHC class II peptide-binding groove, thereby preventing premature loading of peptides. Different MHC class II alleles exhibit distinct affinities for CLIP, and a low affinity interaction has been associated with decreased dependence upon H-2M and increased susceptibility to rheumatoid arthritis, suggesting that decreased CLIP affinity alters the MHC class II-bound peptide repertoire, thereby promoting autoimmunity. To examine the role of CLIP affinity in determining the MHC class II peptide repertoire, we generated transgenic mice expressing either wild-type human Ii or human Ii containing a CLIP region of low affinity for MHC class II. Our data indicate that although degradation intermediates of Ii containing a CLIP region with decreased affinity for MHC class II do not remain associated with I-A(b), this does not substantially alter the peptide repertoire bound by MHC class II or increase autoimmune susceptibility in the mice. This implies that the affinity of the CLIP:MHC class II interaction is not a strong contributory factor in determining the probability of developing autoimmunity. In contrast, in the absence of H-2M, MHC class II peptide repertoire diversity is enhanced by decreasing the affinity of CLIP for MHC class II, although MHC class II cell surface expression is reduced. Thus, we show clearly, in vivo, the critical chaperone function of H-2M, which preserves MHC class II molecules for high affinity peptide binding upon dissociation of Ii degradation intermediates.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15034026     DOI: 10.4049/jimmunol.172.7.4142

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  DM influences the abundance of major histocompatibility complex class II alleles with low affinity for class II-associated invariant chain peptides via multiple mechanisms.

Authors:  Cornelia H Rinderknecht; Sujin Roh; Achal Pashine; Michael P Belmares; Namrata S Patil; Ning Lu; Phi Truong; Tieying Hou; Claudia Macaubas; Taejin Yoon; Nan Wang; Robert Busch; Elizabeth D Mellins
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

2.  Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cells.

Authors:  Azizul Haque; Laela M Hajiaghamohseni; Ping Li; Katherine Toomy; Janice S Blum
Journal:  Cell Immunol       Date:  2007-12-11       Impact factor: 4.868

3.  An MHC class II restriction bias in CD4 T cell responses toward I-A is altered to I-E in DM-deficient mice.

Authors:  Paula R Menges; Scott A Jenks; Elizabeth K Bikoff; David R Friedmann; Zackery A G Knowlden; Andrea J Sant
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

4.  An insertion mutant in DQA1*0501 restores susceptibility to HLA-DM: implications for disease associations.

Authors:  Tieying Hou; Henriette Macmillan; Zhenjun Chen; Catherine L Keech; Xi Jin; John Sidney; Michael Strohman; Taejin Yoon; Elizabeth D Mellins
Journal:  J Immunol       Date:  2011-07-20       Impact factor: 5.422

5.  HLA-DM constrains epitope selection in the human CD4 T cell response to vaccinia virus by favoring the presentation of peptides with longer HLA-DM-mediated half-lives.

Authors:  Liusong Yin; J Mauricio Calvo-Calle; Omar Dominguez-Amorocho; Lawrence J Stern
Journal:  J Immunol       Date:  2012-09-10       Impact factor: 5.422

6.  Complexes of two cohorts of CLIP peptides and HLA-DQ2 of the autoimmune DR3-DQ2 haplotype are poor substrates for HLA-DM.

Authors:  Elizabeth D Mellins; Ludvig M Sollid; Lars-Egil Fallang; Sujin Roh; Anders Holm; Elin Bergseng; Taejin Yoon; Burkhard Fleckenstein; Arunima Bandyopadhyay
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

Review 7.  HLA-DO and Its Role in MHC Class II Antigen Presentation.

Authors:  Yuri O Poluektov; Aeryon Kim; Scheherazade Sadegh-Nasseri
Journal:  Front Immunol       Date:  2013-08-29       Impact factor: 7.561

Review 8.  Human leukocyte Antigen-DM polymorphisms in autoimmune diseases.

Authors:  Miguel Alvaro-Benito; Eliot Morrison; Marek Wieczorek; Jana Sticht; Christian Freund
Journal:  Open Biol       Date:  2016-08       Impact factor: 6.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.